$KN

What Knowles (KN) Said on Its Q3 Earnings Call

Knowles (KN) reported Q3 earnings, highlighting capacity expansion plans and strong demand in precision devices and hearing health. Revenue grew 4% YoY in med tech and specialty audio. The company expects 14% YoY revenue growth in Q4 and 16% for 2026, with margin expansion. Knowles also announced a $15M defense order and plans for increased capital spending in 2027.

Original reporting
Published Oct 22, 2026, 11:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What Knowles (KN) Said on Its Q3 Earnings Call — source image
Decision brief

The 30-second read

$KNBullishMed
01

Why it matters

The guidance suggests accelerated growth and margin expansion, likely supporting a price rally.

02

Market read

First disclosure of detailed 2027 guidance; material for traders evaluating KN and sector peers.

03

What to watch

Potential supply‑chain constraints and the $15 M defense order spread over 36 months may limit near‑term cash.

Relevance 8/10Novelty 8/10Timing: immediate post‑earnings

Background

Knowles (NYSE:KN) reported Q3 results and provided 2027 outlook, including capacity additions and share repurchase.

Company-level read

Ticker impact

$KNBullishHigh confidence
Context

Q3 earnings call disclosed new 2027 guidance, capacity expansion timeline, and share repurchase details.

Expected impact

upward pressure as investors price in higher growth and margin outlook

Evidence & confidence

Guidance exceeds prior expectations and includes higher capital spending, indicating confidence in demand.

Market effects

Positive signal for precision devices and med‑tech audio components, may lift peers.

U.S. technology sector could see modest gains.

Limited to companies with similar product lines; no broad macro effect.

Counterpoint

Higher capital spending could strain cash flow if demand softens, risking margin pressure.

Key entities

  • Knowles Corporation

    Manufacturer of precision devices and med‑tech audio components.

  • John Anderson

    Chief Financial Officer providing guidance details.

Related articles

$KNMed

Knowles (KN) Q3 2026 Earnings Call Transcript

Knowles (KN) reported Q3 2026 revenue of $184M, up 20% YoY, with EPS at $0.38. MedTech & Specialty Audio revenue grew 4% YoY to $67M, while Precision Devices revenue surged 33% YoY to $117M. The company expects Q4 revenue between $180M and $190M, up 14% YoY at the midpoint. Knowles repurchased $25M in shares and reduced debt, maintaining a strong balance sheet.

$KNHighAI 8/10

Knowles surges on earnings beat and strong guidance

Knowles Corporation (NYSE:KN) reported Q3 earnings of $0.38 per share, beating estimates of $0.36, with revenue of $184M, surpassing expectations of $172.1M. The company issued Q4 guidance above forecasts, with EPS expected between $0.39-$0.43 and revenue between $180M-$190M. Shares rose 2.8% in after-hours trading.